BioLineRx Ltd. (BLRX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-14
4:03 pm
Purchase
2025-06-3013GBIOLINERX LTD SPONSORED ADR $0
BLRX
HIGHBRIDGE CAPITAL MANAGEMENT LLC172,950,600
7.200%
172,950,600increase
(New Position)
Filing
History
2025-01-10
6:51 pm
Purchase
2025-01-0613GBIOLINERX LTD SPONSORED ADR NE
BLRX
Mitchell P. Kopin2,555,903
4.990%
2,555,671increase
(+1101582.33%)
Filing
History
2023-10-26
2:18 pm
Purchase
2023-10-0913DBIOLINERX LTD SPONSORED ADR NE
BLRX
Hong Seng Technology Ltd2,560,926
9.500%
2,560,926increase
(New Position)
Filing
History
2022-02-11
06:49 am
Sale
2021-12-3113GAKANDA CORP COM
AKAN
Mitchell P. Kopin594
1.000%
-937decrease
(-61.20%)
Filing
History